Press Releases

Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020

March 26, 2020

Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants

March 5, 2020

Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule

January 13, 2020

Titan Pharmaceuticals Announces Pricing of $2.2 Million Registered Direct Offering

January 7, 2020